Summary Nuclear magnetic resonance (NMR) proton imaging and measurements of the parameters T1 and T2, have been carried out in vivo on the murine mammary tumour T50/80. Tumours had been treated 24h previously by photodynamic therapy (PDT, using haematoporphyrin derivative and 630nm laser light). Proton images clearly demarcated a high signal-intensity region on the side of the tumour closest to the incident light beam, while the parts of the tumour more remote from the beam resembled the images from untreated controls. Both T, and T2 values were raised in the high-intensity region. This high-intensity region was shown to correspond to PDT-induced histological necrosis, the low-intensity region to histologically intact tumour. Linear regression analysis of the relationship of depth of necrosis measured histologically and 'depth of necrosis' measured from the NMR images, yielded a slope of 0.93 (r2=0.95).
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There is increasing experimental and clinical interest in photodynamic therapy (PDT) , in which the combination of visible light and photosensitising drugs produces locally cytotoxic chemical moieties. A principal mode of action of PDT in vivo is thought to be acute injury to the vasculature of both tumours (e.g. Henderson et al., 1985) and normal tissues (e.g. Berenbaum et al., 1986; Benstead & Moore, 1988) . In tumours, vascular collapse leads to prompt and massive secondary ischaemic necrosis of the malignant cells. This classical form of cell death is characterised by failure of large numbers of contiguous cells to maintain homoeostatic regulation of fluid volume, together with early cessation of mitochondrial energy metabolism (Trump & Arstila, 1975) . This contrasts with the form of cell death ('apoptosis'; reviewed by Kerr et al., 1987) were implanted as a brei in the subcutaneous tissues of the abdominal flank, and used experimentally when they reached an average depth, normal to the body wall, of 9 mm (average length of 1.5cm).
Photosensitising drug
Haematoporphyrin derivative (HPD; Paisley Biochemicals, Paisley, Scotland) was obtained and used as a 5mgml-1 solution in 0.9% saline. HPD was injected intraperitoneally at a well-tolerated dose of 40mgkg-1 and the animals were kept in the dark for 24 h and then treated by laser light. The dose of drug, which falls within the reciprocity region for this drug-laser-tumour-effect combination, was selected in order to minimise the length of laser exposure required to achieve the biological effect.
Laser irradiation
A 10W copper vapour laser (Oxford Lasers, Oxford) was used to pump a dye laser that generated 630nm red light.
This was focused into a 1 mm diameter quartz fibre. The diverging beam from this fibre was directed vertically downward to produce a circular field of 3.5cm diameter at a distance equivalent to that at which the centre of the tumour would lie. The laser beam was not completely 'flat' normal to the longitudinal axis, accordingly a relatively large beam diameter was chosen in order to minimise inhomogeneities of fluence across the approximately 1.5 cm length of these tumours. The power density of light at this distance was adjusted to 100mW cm-2, as measured by a thermopile. The light doses given were expressed in terms of fluence at this distance, in Jcm-2. Unanaesthetised mice were placed prone in a jig that protected the whole body other than the tumour from the laser light. Single doses of 87.5-125 J cm-2 were given. The vertical axis of the beam was marked on the skin overlying the tumour and the mice were then housed under subdued light for 24h.
NMR
Proton images of the tumours were obtained using a 'Biospec' system (Bruker/Oxford Research Systems, Coventry), with a 4.7T, 15cm horizontal bore, magnet. Animals were anaesthetised during imaging by an i.p. inection of 0.1 ml of a 50mg ml 1 solution of 'Ketalar' (Parke-Davis, Pontypool) and positioned in the same perspex holder that had been used for their irradiation by light. A single turn surface coil (Ackerman et al., 1980) of 3 cm diamater, was placed just above the tumour (Figure 1 ). Images were acquired in the plane of the coil, using a spin Direction of prior laser illumination Tumour on flank Surface RF coil Figure 1 Schematic of the imaging set-up (components not to scale). The longitudinal axis of prior laser illumination was in the plane of the paper; the tumour which lay normal to the flank, had been illuminated on its upper aspect; and the RF coil overlay the tumour, again in the plane of the paper.
echo pulse sequence. A 90°'hard' pulse of between 15 and 40 ps duration was used, depending on the position of the slice of interest relative to the plane of the coil. A frequencyselective refocusing pulse of 6 ms duration was used in a slice selection gradient of 22mT m-1, to give a slice of l mm thickness. This particular combination of pulses was used as, in our hands, it avoided rapid changes in magnetic field which can lead to artefacts in imaging. Repetition time (TR) was 1.55s and echo delay time (TE) was 52ms. The overall imaging time was 6 min 36s for a 256 x 256 image, with inplane resolution of 120 x 120 pm, for the 3.1 cm field of view.
To obtain T1 and T2 times, phase encoding was reduced to 128 steps. 
Histology
Immediately after NMR imaging, the mice were killed painlessly by anaesthesia. The animals were anaesthetised while still within the jigs in which they had been imaged, in order to maintain the spatial relationships of the planes of laser irradiation, imaging and histology. The tumour was then partially bisected in the marked plane of irradiation, the mouse removed from the jig, and the tumour dissected free and fully bisected. The tumour was then fixed for histology, using Bouin's fluid to prevent shrinkage. Three-pm thick sections were made from the cut, equatorial faces of the tumour halves and then stained with Haematoxylin and Eosin.
Results

NMR
Proton images of T50/80 tumours that had received drug alone or light alone were indistinguishable from those of untreated control tumours, and were as shown in Figure 2 . The images just resolved the normal skin overlying the tumour; the dark region between skin and tumour may be the fibrous capsule that surrounds this neoplasm. Within the tumour mass, the characteristically stippled appearance of T50/80 images is believed to reflect the presence of numerous discrete foci of 'old' coagulative necrosis (Figure 3c ). NMR images acquired 24 h after PDT show clearly the effects of therapy (Figure 3a) . The peripheral bright area represents the prompt oedema and inflammatory infiltration of the dermis of the skin that is a common feature of external treatments by PDT. On the side of the tumour closest to the incident light beam, an area with high average signal inten- (Table I ). In turn, values for the high-intensity region of the tumour were significantly (P<0.05) higher than those for the lower intensity region. Although statistically significant, the differences in T1 and T2 between the two regions of the tumour are insufficient of themselves to account for the differences in the image intensities. For image intensities given by: S=So(l-e-TR/T) (e-TE/T2), a % contrast between necrotic and viable zones could be calculated by: 100 x (Sn-Sv)/Sv. Adopting the values for T1 and T2 given in Table I , then for a TE of 52ms and TR of 1.552s the predicted % contrast is 15%, assuming equal proton densities. However, the observed contrasts in image intensity in the different tumours ranged from 23 to 44%.
Comparison of histological sections and NMR images
The object was to compare the appearance of an NMR image with that of a section through the tumour with which that image corresponded spatially. Accordingly, a uniform method of analysis was adopted for both. Each coded tumour section was scanned at right angles to the incident light beam, at intervals of 0.4mm. For each position, and in a plane corresponding to the vertical axis of the light beam, measurement was made of the depth of tumour tissue adjudged to have been wholly destroyed by PDT ('necrotic' zone; Figure 3b ). This was recognised as containing only congested blood vessels and tumour cells with hyperchromatic, pyknotic or karyorrhectic nuclei, i.e. with no histologically intact cells (defined as those with rounded nuclei containing homogeneous heterochromatin). The inner edge of the necrotic zone was defined as the depth at which the first histologically intact cell was encountered in scanning the plane (below which was the 'viable' zone; Figure 3c ). Twenty-five to 35 measurements were made per tumour. Polaroid photographs of the NMR images were analysed similarly. In this case, the 'necrotic' zone was defined as the region of high signal intensity bounded by the tumour edge nearest the incident light beam and extending a variable distance into the tumour mass (Figure 3a) .
The mean depth of necrosis in tumour sections rose from 2.75 to 4.5mm as the incident light dose was increased from 87.5 to 125Jcm-2. However, for a given dose there was a large variation in depth of histological necrosis between individual tumours (Figure 4a) , and the differences between means for increasing doses were statistically insignificant. Thus, dose was a very poor predictor of PDT effect (using, arbitrarily, a linear regression fit, r2=0.055). In contrast, a plot of depth of histological necrosis as a function of depth of NMR 'necrosis' could be described by the equation: y=0.13 + 0.93x, r2= 0.95 (Figure 4b ).
Discussion
For the particular combinations used here of drug dose, drug-light interval, and power density of external illumination, there was a very wide variation in biological effect for a given applied 'dose' of PDT. In an experimental system, it is possible to optimise the different parameters to reduce some of this variation; for example, since carrying out these initial experiments, we have used extraction methods to show that the amount of HPD that remains at 24 h is widely variable between tumours, but much less so at 6 h (J.V. Moore, to be published separately). In patients, such optimisation procedures are more difficult or even impossible, so that a non- Recently, 31p NMR spectroscopy has been used to detect the early metabolic responses of tumours in vivo to PDT (e.g. Ceckler et al., 1986; Naruse et al., 1986; Chopp et al., ,1987 Figure 4b suggests that for a given depth of NMR 'necrosis', the histological depth of necrosis might be greater or less by up to 1 mm.
(b) That 24h is an appropriate time for comparison of image and histology. Full time-course experiments are currently under way but it is known that the expression of necrosis in tumour cells as a result of hypoxic or ischaemic hypoxia occupies approximately 4-11 h (data from various authors, summarised by Moore, 1987) . One might therefore expect that by 24h after PDT, the great majority of dead cells would have expressed necrosis, while recovery processes
would not yet have occurred to a major extent (e.g. Star et al., 1986; Kaye & Morstyn, 1987 after illumination (e.g. Berenbaum et al., 1986; Kaye & Morstyn, 1987) and may peak at 1 or 2 days before resolving (e.g. Moore et al., 1986; Star et al., 1986) . The choice of the same time, 24 h, to measure both NMR parameters and histology, seems not inappropriate.
(c) That measurement of depth of necrosis at early times is relevant to therapeutic outcome. Brasseur et al. (1987) found that the presence or absence of a strong necrotic reaction 3 days after PDT using a variety of drugs, predicted reasonably well the relative efficacy of the drugs in causing local control of the EMT6 mammary tumour. More directly relevant to the present experiments, Kinsey et al. (1983) demonstrated for a murine mammary tumour that the increasing radius of the necrotic zone, measured histologically 2 days after interstitial laser illumination at progressively higher power densities, corresponded with an increasing delay in regrowth of similarly treated tumours. Using non-invasive NMR imaging, it will be possible to test definitively, for individual animals, the precise relationships of early response and therapeutic outcome. Of particular interest is that very preliminary results suggest that it may be possible to obtain similar images using a low-field strength clinical NMR machine (in our case, a 0.26 T, 11 MHz, Picker instrument). 
